HBeAg Seroconversion During Treatment with Peginterferon-Alfa2a (PEG-IFN) is Preceded by Selection of Hepatitis B Virus Basal Core Promoter and Pre-Core Variants Which Are Associated with Decreased HBV Replication
Journal of Hepatology（2020）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要